Edition:
United Kingdom

Oncopeptides AB (ONCO.ST)

ONCO.ST on Stockholm Stock Exchange

163.40SEK
5:00pm BST
Change (% chg)

4.20kr (+2.64%)
Prev Close
159.20kr
Open
160.00kr
Day's High
167.40kr
Day's Low
160.00kr
Volume
136,255
Avg. Vol
156,175
52-wk High
209.00kr
52-wk Low
60.25kr

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -3.270
Mar '18 0.00 -1.417
FY 2017 Dec '17 0.00 -1.940
Sep '17 0.00 -1.296
Jun '17 0.00 -1.690
Mar '17 0.00 -1.599
FY 2016 Dec '16 0.00 -2.067
Sep '16 0.00 -1.060
Jun '16 0.00 -1.190
Mar '16 0.00 -0.920
 
*Note: Units in Millions ofSwedish Krona
**Note: Units in Swedish Krona

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 2 0.00 0.00 0.00 0.00
Year Ending Dec-19 3 74.67 224.00 0.00 0.00
Earnings (per share)
Year Ending Dec-18 2 -9.50 -9.12 -9.88 -6.73
Year Ending Dec-19 3 -6.99 -4.77 -8.82 -4.80
Sales and Profit Figures in Swedish Krona (SEK);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.70 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta -- 0.93 0.89
Price to Sales (TTM) -- 114.98 5.74
Price to Book (MRQ) 4.74 15.51 5.00
Price to Tangible Book (MRQ) 4.74 14.62 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions -- 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 411.53 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 80.36 5.63
Sales - 5 Yr. Growth Rate -- 32.26 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -41.99 29.14 20.61
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.42 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 9.54 5.46 3.03
LT Debt to Equity (MRQ) 0.00 35.27 12.51
Total Debt to Equity (MRQ) 0.00 37.09 16.85
Interest Coverage (TTM) -- -102.34 32.65

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.18 54.37
Gross Margin - 5 Yr. Avg. -- 50.58 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -600.62 10.68
Operating Margin (TTM) -- -759.72 4.32
Operating Margin - 5 Yr. Avg. -- -621.65 6.11
Pre-Tax Margin (TTM) -- -733.57 5.18
Pre-Tax Margin - 5 Yr. Avg. -- -627.35 6.51
Net Profit Margin (TTM) -- -734.94 1.48
Net Profit Margin - 5 Yr. Avg. -- -630.39 2.78
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,228,954 860,374,110
Net Income/Employee (TTM) -22,784,650 3,144,136 101,207,069
Receivable Turnover (TTM) -- 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.00 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -66.83 -0.15 11.13
Return on Assets - 5 Yr. Avg. -- 3.51 12.40
Return on Investment (TTM) -76.13 1.78 14.61
Return on Investment - 5 Yr. Avg. -- 2.56 16.13
Return on Equity (TTM) -76.18 3.27 16.33
Return on Equity - 5 Yr. Avg. -- 3.43 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -114.56 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Oncopeptides AB

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -1.17 -- 73 52
13 Week -1.17 -- 96 66
26 Week 43.67 -- 99 80
52 Week -- -- -- 50
YTD -- -- -- 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 80.42%
# of Holders: 33
Total Shares Held: 35,422,895
3 Mo. Net Change: -335,393
# New Positions: 5
# Closed Positions: 1
# Increased Positions: 9
# Reduced Positions: 9
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.